NCT06285084

Brief Summary

The goal of this observationl study is to evaluate the possibility of building a Deep Learning (DL) model capable of analyzing electrocardiographic traces of athletes and providing information in the form of a probability stratification of cardiovascular disease. Researchers will enroll a training cohort of 455 participants, evaluated following standard clinical practice for eligibility in competitive sports. The response of the clinical evaluation and ECG traces will be recorded to build a DL model. Researchers will subsequently enroll a validation cohort of 76 participants. ECG traces will be analyzed to evaluate the accuracy of the model to discriminate participants cleared for sports eligibility versus participants who need further medical tests

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
531

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started Feb 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Feb 2024Feb 2027

Study Start

First participant enrolled

February 2, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

February 5, 2024

Completed
24 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2025

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2027

Expected
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

1.8 years

First QC Date

February 5, 2024

Last Update Submit

February 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • DL model accuracy

    The accuracy of the DL model in recognizing the ECGs of athletes deemed fit or unfit will be evaluated by comparing the results with those obtained from the assessment performed by the sports physician (gold standard). Participants will categorize the athletes into true positives, false positives, true negatives, and false negatives. To define the ability of the DL model to discriminate between ECGs of athletes deemed fit or unfit, the receiver operating characteristic (ROC) curve and the corresponding area under the curve (AUC) will be calculated.

    From first medical evaluation with ECG until the final medical decision on competitive sports eligibility, up to 12 months

Study Arms (2)

Training Cohort

455 Athletes already evaluated for sports participation clearance, whom ECG and clinical evaluation (cleared - not cleared for competitive sports participation) will be fed into the DL model

Validation Cohort

76 Athletes evaluated using standard sports eligibility clearance tests and our DL model

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adults requiring medical evaluation for competitive sports eligibility

You may qualify if:

  • Athletes in need of cardiac or sports medical evaluation for the issuance of competitive eligibility.
  • Enlisted athletes involved in sports like soccer or those with mixed or aerobic cardiovascular demands according to the COCIS 2017 classification.
  • Aged 18 years or older but not exceeding 60 years.
  • No history of cardiovascular disease.
  • Signed Informed Consent.

You may not qualify if:

  • Athletes engaging in skill-based sports as per the COCIS 2017 classification.
  • High clinical probability of cardiovascular disease, such as typical angina or heart failure.
  • Pregnancy and/or breastfeeding (confirmed through self-declaration).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale Galeazzi-Sant'Ambrogio

Milan, Lombardy, 20157, Italy

RECRUITING

Central Study Contacts

Daniele Andreini, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2024

First Posted

February 29, 2024

Study Start

February 2, 2024

Primary Completion

November 2, 2025

Study Completion (Estimated)

February 2, 2027

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations